MedPath

Improving Access to Eye Care in Glaucoma Patients

Not Applicable
Completed
Conditions
Glaucoma
Interventions
Behavioral: Reminder letter Intervention
Registration Number
NCT02982629
Lead Sponsor
Wills Eye
Brief Summary

1. To design and develop a prospective, randomized pilot study utilizing information from electronic medical records to address follow-up adherence and reduce the gap between recommended and actual follow-up adherence in patients with glaucoma.

2. To evaluate the impact of a telephone-based intervention on follow-up adherence in patients with glaucoma using a randomly assigned comparison with usual care.

Detailed Description

The Wills Eye Health System (WEHS) proposes to conduct a pilot study to evaluate the feasibility and effectiveness of a telephone-based intervention to improve rates of follow-up exams in patients with glaucoma. The prospective, randomized, controlled trial entitled "Improving Access to Eye Care in Patients with Glaucoma" will utilize cohort data from 2013 electronic medical record information to reduce the gap between recommended and actual follow-up utilization of eye care services in glaucoma patients. Patients with glaucoma will be recruited from the Wills Eye Glaucoma clinic who were seen between 3/1/13 and 10/31/13. A recall list will be generated for patients who have scheduled follow-up appointments from 9/1/13 to 11/30/13. These patients will be randomly assigned to the "Usual Care" group or "Intervention" group. The primary outcome will be successful attendance at a follow-up appointment within an appropriate time frame. This intervention is based on a CDC funded project at Wills to improve access to eye care in patients with diabetes. Thus, this pilot study will test the efficacy of a telephone-based intervention to improve follow-up adherence in patients with glaucoma by improving access to eye care.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Attended Wills Eye Glaucoma Clinic from 9/1/12 and 10/31/13
Exclusion Criteria
  • Any medical condition that would preclude the subject from providing reliable and valid data.
  • Recommended to f/u in less than 1 month time period.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Usual CareReminder letter InterventionPatients in this group do not receive any letters or phone calls after missing follow-up appointment.
Reminder Letter InterventionReminder letter InterventionPatients in this group receive letters and phone calls after missing follow-up appointment to reschedule the appointment.
Primary Outcome Measures
NameTimeMethod
Adherence to Follow-Up28 weeks

Whether patients adhere to follow-up appointments at 28 weeks.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath